Jump to content
RemedySpot.com

new JAMA editorials on drug safety issues

Rate this topic


Guest guest

Recommended Posts

http://jama.ama-assn.org/cgi/content/full/292.21.2647v1

Postmarketing Surveillance—Lack of Vigilance, Lack of Trust

http://jama.ama-assn.org/cgi/content/full/292.21.2643v1

Potential for Conflict of Interest in the Evaluation of Suspected

Adverse Drug Reactions: A Counterpoint

Full-text is free in this case and does not require subscription.

Barbara

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...